Bristol-Myers Squibb Co
Change company Symbol lookup
Select an option...
BMY Bristol-Myers Squibb Co
EGFEY Eurobank Ergasias SA
FB Facebook Inc
BABA Alibaba Group Holding Ltd
SWN Southwestern Energy Co
KBH KB Home
ANF Abercrombie & Fitch Co
TWTR Twitter Inc
HMNY Helios and Matheson Analytics Inc
JYNT Joint Corp
Go

Health Care : Pharmaceuticals | Large Cap BlendCompany profile

Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Company's pharmaceutical products include chemically synthesized drugs, or small molecules, and products produced from biological processes called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. The Company's products include Empliciti, Opdivo, Sprycel, Yervoy, Eliquis, Orencia, Baraclude, Hepatitis C Franchise, Reyataz Franchise and Sustiva Franchise. It offers products for a range of therapeutic classes, which include virology, including human immunodeficiency virus (HIV) infection; oncology; immunoscience, and cardiovascular. Its products are sold to wholesalers, retail pharmacies, hospitals, government entities and the medical profession across the world.

Price
Delayed
$58.90
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)

Today's volume of 50,449 shares is on pace to be much lighter than BMY's 10-day average volume of 7,558,397 shares.

50,449
  • Prev Close
    58.90
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    7.6M
  • Last (time)
    4:00p ET 10/17/18
  • Last (size)
    65
  • 52-Wk Range
    49.96 - 70.05
    LowHigh
  • (02/16/18 - 05/08/18)
    17.89%
  • 23.1%
  • Market Cap
    96.3B
  • Shares Outstanding
    1.6B
  • 2.01
  • 29.27x
  • $1.60/2.72%
  • Ex-dividend
    10/04/18
  • 0.9
  • 71.80
  • (% of float 09/28/18)
    0.83

Latest News

October 17, 2018
6:59 am ET
BusinessWire
October 12, 2018
7:04 am ET
MarketWatch
6:59 am ET
BusinessWire
6:59 am ET
MarketWatch
October 11, 2018
2:39 pm ET
MarketWatch
7:15 am ET
MarketWatch
6:59 am ET
BusinessWire
October 09, 2018
7:00 am ET
BusinessWire
October 05, 2018
6:57 am ET
MarketWatch
October 02, 2018
11:27 am ET
MarketWatch
September 28, 2018
5:48 am ET
BusinessWire
September 19, 2018
9:45 am ET
BusinessWire
6:04 am ET
BusinessWire
September 18, 2018
6:59 am ET
BusinessWire
September 12, 2018
4:09 pm ET
BusinessWire
9:02 am ET
Globe Newswire
2:00 am ET
BusinessWire
September 06, 2018
3:00 pm ET
BusinessWire
6:59 am ET
BusinessWire
September 05, 2018
6:59 am ET
BusinessWire
September 04, 2018
4:30 pm ET
PR Newswire
August 31, 2018
9:00 am ET
PR Newswire
August 30, 2018
6:59 am ET
BusinessWire
August 28, 2018
9:00 am ET
BusinessWire
August 24, 2018
8:44 am ET
MarketWatch
August 23, 2018
6:59 am ET
BusinessWire
August 17, 2018
7:09 am ET
MarketWatch
7:02 am ET
MarketWatch
6:59 am ET
BusinessWire
August 15, 2018
9:00 am ET
PR Newswire
August 09, 2018
8:00 am ET
Globe Newswire
August 08, 2018
4:10 pm ET
PR Newswire
8:10 am ET
Globe Newswire
August 07, 2018
7:54 am ET
MarketWatch
August 01, 2018
8:00 am ET
BusinessWire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2018 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2018. All rights reserved.